Imunon (IMNN)Officer sold ~$1.7K

~$1.7K

Approx. value · 920 sh @ $1.88

2,896

Holds after · shares reported

Traded

Jul 6, 2026

Filed

Jul 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 12, 2026Company filing · Form 8-K · ResultsReported its results
2. Jun 1, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 3 more items)
3. Jun 16, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“At the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Imunon, Inc. (the “Company”) held on June 16, 2026, the Company’s stockholders approved an amendment to the IMUNON, Inc. 2018 Stock Incentive Plan (the “Plan”), which amendment was approved by the Company’s board of directors on February 27, 2026.”
4. Jun 29, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 29, 2026, Jeffrey Church informed Imunon, Inc. (the “Company”) of his intent to retire from the position of interim Chief Financial Officer (a position he has held since January of 2026), effective July 1, 2026 (the “Retirement Date”).”
5. Jun 29, 2026InsiderOfficer sold ~$21K of IMNN shares in the open market
6. Jul 6, 2026 · this disclosureInsiderOfficer sold ~$1.7K of IMNN shares in the open market

What came next

1. Jul 20, 2026InsiderOfficer sold ~$3.8K of IMNN shares in the open market
2. Aug 3, 2026InsiderOfficer sold ~$4K of IMNN shares in the open market
3. Aug 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“The Compensation Committee and the Board of Directors of Imunon, Inc. (the “Company”), as applicable, approved compensatory programs for certain executive officers, pursuant to which such executive officers may elect to receive a percentage of their base salary in the form of shares of common stock and will receive additional shares of common stock in connection with such election.”
4. Aug 11, 2026Company filing · Form 8-K · ResultsReported its results
5. Aug 17, 2026InsiderOfficer sold ~$4K of IMNN shares in the open market
6. Aug 31, 2026InsiderOfficer sold ~$3.9K of IMNN shares in the open market
7. Sep 28, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Imunon

For Imunon, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMNN page.

Other recent filings by Susan Eylward, General Counsel and Corp Sec

• SEC Form 4 at Imunon (IMNN)Sep 1, 2026
• SEC Form 4 at Imunon (IMNN)Aug 17, 2026
• SEC Form 4 at Imunon (IMNN)Aug 4, 2026
• SEC Form 4 at Imunon (IMNN)Jul 21, 2026
• SEC Form 4 at Imunon (IMNN)Jun 29, 2026

The full history of Susan Eylward, General Counsel and Corp Sec is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Imunon

• SEC Form 4Sep 1, 2026
• SEC Form 4Aug 17, 2026
• SEC Form 4Aug 4, 2026
• SEC Form 4Jul 21, 2026
• SEC Form 4Jun 29, 2026
• SEC Form 4Jan 28, 2025

Everything OQRO holds on this company is on its IMNN page.